| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors), ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC16H21N3O2S | 
| InChIKeyOIJDBECSPSHUGA-CYBMUJFWSA-N | 
| CAS Registry1258833-31-6 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Glaucoma | Phase 2 | Japan  | 01 Jul 2018 | |
| Choroidal Neovascularization | Preclinical | - | 07 May 2017 | |
| Choroidal Neovascularization | Preclinical | Japan  | 07 May 2017 | |
| Glaucoma, Open-Angle | Discovery | Japan  | 06 Sep 2019 | 





